127 related articles for article (PubMed ID: 28955297)
1. Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells.
Jin F; Han GK; Zhang H; Zhang R; Li GH; Feng S; Qin XY; Kong LS; Nie QM; Li HR; Zhao L
Front Neurol; 2017; 8():474. PubMed ID: 28955297
[TBL] [Abstract][Full Text] [Related]
2. Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells.
Li G; Zhang H; Liu Y; Kong L; Guo Q; Jin F
Exp Ther Med; 2015 Mar; 9(3):744-750. PubMed ID: 25667622
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of antisense and dominant-negative AKT2 constructs on proliferation of glioma cell line TJ905].
Kang CS; Pu PY; Li J; Wang GX
Ai Zheng; 2004 Nov; 23(11):1267-72. PubMed ID: 15522171
[TBL] [Abstract][Full Text] [Related]
4. [Influence of SEPT7 on biological characters of glioma cell line TJ905].
Jia ZF; Pu PY; Kang CS; Wang GX; Zhang ZY; Qiu MZ; Huang Q
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(20):1420-3. PubMed ID: 18241599
[TBL] [Abstract][Full Text] [Related]
5. Effect of ERBB2 expression on invasiveness of glioma TJ905 cells.
Xu GF; Xie WF
Asian Pac J Trop Med; 2013 Dec; 6(12):964-7. PubMed ID: 24144028
[TBL] [Abstract][Full Text] [Related]
6. [Expression of anti-apoptotic and multi-drug resistance-associated protein genes in cancer stem cell isolated from TJ905 glioblastoma multiforme cell line].
Jin F; Li HS; Zhao L; Wei YJ; Zhang H; Guo YJ; Pang R; Jiang XB; Zhao HY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2312-6. PubMed ID: 19087689
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
8. Effect of siRNA-Livin on drug resistance to chemotherapy in glioma U251 cells and CD133
Liu Y; Guo Q; Zhang H; Li GH; Feng S; Yu XZ; Kong LS; Zhao L; Jin F
Exp Ther Med; 2015 Oct; 10(4):1317-1323. PubMed ID: 26622485
[TBL] [Abstract][Full Text] [Related]
9. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
Xu W; Chang H; Qin CK; Zhai YP
Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
Zhang X; Ni Q; Wang Y; Fan H; Li Y
Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
[TBL] [Abstract][Full Text] [Related]
11. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
[TBL] [Abstract][Full Text] [Related]
12. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
Yang C; He L; Chen G; Ning Z; Xia Z
Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
[TBL] [Abstract][Full Text] [Related]
13. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
[TBL] [Abstract][Full Text] [Related]
14. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
15. Effects of valproic acid on the susceptibility of human glioma stem cells for TMZ and ACNU.
Li Z; Xia Y; Bu X; Yang D; Yuan Y; Guo X; Zhang G; Wang Z; Jiao J
Oncol Lett; 2018 Jun; 15(6):9877-9883. PubMed ID: 29805689
[TBL] [Abstract][Full Text] [Related]
16. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
17. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.
Li M; Liang RF; Wang X; Mao Q; Liu YH
Oncol Lett; 2017 Dec; 14(6):6597-6603. PubMed ID: 29151909
[TBL] [Abstract][Full Text] [Related]
18. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM
Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261
[TBL] [Abstract][Full Text] [Related]
19. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells.
Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL; He DL; Zhao J
Acta Pharmacol Sin; 2007 Dec; 28(12):1968-74. PubMed ID: 18031611
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
